Gamida Cell raised $35,000,000 on , from Novartis.

Get alertedif Gamida Cell gets funded!
Amount:$35,000,000
Company:
Investors:
Industry:Biotechnology
Country:
City:
Israel
Jerusalem
Key people:Naftali Brikashvili (CFO)
Dorit Harati (VP, Quality Assurance)
Ruben Krupik (Chairman of the Board)
Frederick M. Miesowicz (Vice President of U.S. Operations)
Yael Margolin (President, CEO & Board of Directors)
Tony Peled (Co - Founder, Chief Scientific Officer & VP, R&D)
David Snyder (VP, Clinical Development & Regulatory Affairs)
Data sources:
www.finsmes.com - Gamida Cell an Israel-based provider of stem cell tech received a $35m investment http://t.co/DB1GO7xgjl
www.owler.com - Gamida Cell received $35M in Unattributed Funding http://t.co/kC7zJsxJ5I
ct.moreover.com - Gamida Cell Receives $35M Investment from Novartis Pharma http://t.co/FJ31fKsUG2 #CancerNews
Description:
An amount of 35M was completed by Gamida Cell in a securities offering. The date of the round is August 22nd, 2014. Gamida Cell specializes in Biotechnology.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!